Cleared Traditional

K932611 - NEUROMUSCULAR STIMULATOR

K932611 is an FDA 510(k) clearance for NEUROMUSCULAR STIMULATOR, manufactured by Myo/Kinetic Systems, Inc.. The device is a Class 2 Neurology device with product code GZJ cleared through the Traditional 510(k) pathway after a 248-day FDA review.

K932611 · Myo/Kinetic Systems, Inc. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1994
Decision
248d
Days
Class 2
Risk

K932611 is an FDA 510(k) clearance for the NEUROMUSCULAR STIMULATOR. Classified as Stimulator, Nerve, Transcutaneous, For Pain Relief (product code GZJ), Class II - Special Controls.

Submitted by Myo/Kinetic Systems, Inc. (Menomonee Falls, US). The FDA issued a Cleared decision on January 31, 1994 after a review of 248 days - an extended review cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5890 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Myo/Kinetic Systems, Inc. devices

FDA 510(k) Submission Details - K932611

510(k) Number K932611 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 28, 1993
Decision Date January 31, 1994
Days to Decision 248 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
100d slower than avg
Panel avg: 148d · This submission: 248d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GZJ Device Classification - Class 2, Special Controls

Product Code GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5890
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief

All 141
Devices cleared under the same product code (GZJ) and FDA review panel - the closest regulatory comparables to K932611.
THERAPEUTIC ULTRASOUND AND STIMULATOR
K935324 · Chattanooga Group, Inc. · May 1994
HOME MICROCURRENT HMC
K935132 · Medical Devices, Inc. · Mar 1994
FLEXMATE
K934619 · Medical Devices, Inc. · Feb 1994
THERA PULSE A ELECTRO NERVE STIMULATOR
K925686 · Biomedical Life Systems, Inc. · Mar 1993
INTELECT 600MP
K920260 · Chattanooga Group, Inc. · Oct 1992
TEAM-MC II
K921828 · Henley Intl. · Sep 1992